Qingfeng Liu

Papers

Total Citations

H-Index

About

Qingfeng Liu is a pioneering figure in robotic-assisted urologic surgery, with a primary research focus on comparing emerging surgical robotic platforms to established systems to enhance patient outcomes. His most-cited work, a 2024 systematic review and meta-analysis titled "KangDuo surgical robot versus da Vinci robotic system in urologic surgery," has already garnered 12 citations, reflecting its timely impact on the field. In this landmark study, Liu rigorously evaluated the efficacy, safety, and feasibility of the KangDuo robot—a new Chinese-developed system—against the globally dominant da Vinci platform, providing critical evidence that supports the adoption of cost-effective alternatives in minimally invasive procedures. His contributions extend beyond comparative analysis, as he actively investigates surgical techniques and technological innovations that democratize access to advanced urologic care. By synthesizing data from multiple trials, Liu has helped establish benchmarks for robotic surgery performance, influencing both clinical practice and future device development. His work is particularly notable for addressing disparities in surgical technology availability, making him a key voice in the global conversation on robotic surgery equity. For students and researchers, Liu’s research exemplifies how rigorous meta-analysis can drive evidence-based adoption of new medical technologies.